Sarah E Messmer
Biographic Data
| ID | 7449354 |
|---|---|
| NAME | Sarah E Messmer |
| GIVEN NAMES | Sarah E |
| FAMILY NAME | Messmer |
| SIGNATURE | MESSMER S E |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Stronger, longer, better opioid antagonists? Nalmefene is NOT a naloxone replacement
The fatal overdose crisis claims nearly 200 lives daily in the United States (U.S). Evolutions in the illicit drug supply, such as the addition of sedative adulterants and a shift to synthetic opioids such as fentanyl, have driven increasing rates of both fatal and non-fatal overdose. Specifically, synthetic opioid usage of fentanyl was implicated in 68 % of the U.S. drug overdose deaths in 2022 alone. This has placed tremendous burden on communi…
No prominent works on this page.
Stronger, longer, better opioid antagonists? Nalmefene is NOT a naloxone replacement
The fatal overdose crisis claims nearly 200 lives daily in the United States (U.S). Evolutions in the illicit drug supply, such as the addition of sedative adulterants and a shift to synthetic opioids such as fentanyl, have driven increasing rates of both fatal and non-fatal overdose. Specifically, synthetic opioid usage of fentanyl was implicated in 68 % of the U.S. drug overdose deaths in 2022 alone. This has placed tremendous burden on communi…
Fentanyl (1 work) · Intensive care medicine (1 work) · Internal Medicine (1 work) · Medicine (1 work) · Nalmefene (1 work) · Naltrexone (1 work) · Opioid (1 work) · Opioid antagonist (1 work) · Opioid overdose (1 work) · Opioid Use Disorder Treatment (1 work)